Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Brain state dynamics in ketamine-induced dissociation resemble those in posttraumatic stress disorder

  • Goldway, Noam
  • Markovits, Taly
  • Fine, Naomi
  • Fruchtman-Steinbok, Tom
  • Gurevitch, Guy
  • Deco, Gustavo
  • Sharon, Haggai
  • Hendler, Talma
Background Dissociation, an altered state of consciousness in which individuals feel detached from their body, environment, and sense of self, is a common feature of posttraumatic stress disorder (PTSD). Despite its significance, the neurocognitive processes underlying dissociation remain poorly understood, potentially limiting diagnostic precision and treatment efficacy in PTSD. Methods To address this gap, we applied network control theory to resting-state functional magnetic resonance imaging to examine neural dynamics during dissociative states in 2 contexts: healthy volunteers ( n = 30) undergoing intravenous administration of ketamine, an anesthetic known to induce dissociative states, and patients with PTSD receiving an intervention aimed at alleviating dissociative symptoms (a secondary analysis of data from 78 patients who participated in previously conducted clinical trials). Results Ketamine administration led to resting-state brain dynamics resembling those observed in patients with PTSD before treatment, characterized by an increased dominance of a default mode network (DMN) meta-state and a decreased dominance of a somatomotor network (SOM) meta-state. Posttreatment reduction in the dominance of the DMN meta-state correlated with a decrease in dissociative symptoms in patients with PTSD. Computational modeling analysis revealed that after treatment, patients with PTSD exhibited a more organized and less entropic brain state. However, contrary to our hypothesis, ketamine administration did not lead to significant changes in these entropy-related indices. Conclusions Dissociative states, whether induced by pharmacological manipulation or clinical condition, are accompanied by increased dominance of the DMN meta-state and reduced dominance of the SOM meta-state., This work was supported by the European Union's Horizon 2020 Framework Programme for Research and Innovation (Grant No. 945539 [Human Brain Project SGA3]), the Israel Science Foundation (Grant No. 2923/20) within the Israel Precision Medicine Partnership, the European Union's Seventh Framework Programme (Grant No. 602186), the Israel Ministry of Commerce Innovation Authority's Kamin Program (Grant No. 67951), and JOY Ventures. NG, NF, and TH contributed to conceptualization. NG, NF, and TF-S contributed to data collection. NG, TM, GG, GD, and TH contributed to formal analysis. NG, TM, GD, HS, and TH contributed to investigation. NG, TM, GG, GD, HS, and TH contributed to methodology. NG, TM, and GD contributed to visualization. NG contributed to writing the original draft of the article. NG, TM, NF, TF-S, GD, HS, and TH contributed to reviewing and editing the article. NG and TH contributed to project administration. TM, GG, and HS contributed to data curation. HS and TH contributed to funding acquisition. TH contributed to supervision. All authors gave final approval for publication and agreed to be held accountable for the work performed therein. We also thank the Sagol Family Fund for their support. We thank the clinicians and researchers who contributed to patient recruitment for the studies included in this project: Dr. Yotam Pasternak, Dr. Roy Sar-El, Dr. Dan Mirelman, Noam Sarna, Nili Green, Gali Bar, Dana Kinori, Maya Weinstein, Dana Natan, Dana Kariti, Professor Michael Krasnoshtein, Dr. Dalia Brandes, Dr. Oren Tene, Efrat Routledge, Marina Gordon, Dr. Miki Bloch, Zivya Seligman, Daphna Armon, and Dr. Liat. A previous version of this article was published as a preprint on PsyArXiv: https://osf.io/preprints/psyarxiv/v52qb_v1. The analysis code and data supporting the findings of this study are available on the Open Science Framework at https://osf.io/46zfm/. TH is the Chief Medical Scientist and Chair of the advisory board at GrayMatters Health Co., Haifa, Israel, and has stock options. This company sells the platform of Prism for PTSD, neurofeedback driven by an amygdala-related biomarker, which is also used as the neurofeedback probe in this study. All other authors report no biomedical financial interests or potential conflicts of interest.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Brain state dynamics in ketamine-induced dissociation resemble those in posttraumatic stress disorder

  • Goldway, Noam
  • Markovits, Taly
  • Fine, Naomi
  • Fruchtman-Steinbok, Tom
  • Gurevitch, Guy
  • Deco, Gustavo
  • Sharon, Haggai
  • Hendler, Talma
Background Dissociation, an altered state of consciousness in which individuals feel detached from their body, environment, and sense of self, is a common feature of posttraumatic stress disorder (PTSD). Despite its significance, the neurocognitive processes underlying dissociation remain poorly understood, potentially limiting diagnostic precision and treatment efficacy in PTSD. Methods To address this gap, we applied network control theory to resting-state functional magnetic resonance imaging to examine neural dynamics during dissociative states in 2 contexts: healthy volunteers ( n = 30) undergoing intravenous administration of ketamine, an anesthetic known to induce dissociative states, and patients with PTSD receiving an intervention aimed at alleviating dissociative symptoms (a secondary analysis of data from 78 patients who participated in previously conducted clinical trials). Results Ketamine administration led to resting-state brain dynamics resembling those observed in patients with PTSD before treatment, characterized by an increased dominance of a default mode network (DMN) meta-state and a decreased dominance of a somatomotor network (SOM) meta-state. Posttreatment reduction in the dominance of the DMN meta-state correlated with a decrease in dissociative symptoms in patients with PTSD. Computational modeling analysis revealed that after treatment, patients with PTSD exhibited a more organized and less entropic brain state. However, contrary to our hypothesis, ketamine administration did not lead to significant changes in these entropy-related indices. Conclusions Dissociative states, whether induced by pharmacological manipulation or clinical condition, are accompanied by increased dominance of the DMN meta-state and reduced dominance of the SOM meta-state., This work was supported by the European Union's Horizon 2020 Framework Programme for Research and Innovation (Grant No. 945539 [Human Brain Project SGA3]), the Israel Science Foundation (Grant No. 2923/20) within the Israel Precision Medicine Partnership, the European Union's Seventh Framework Programme (Grant No. 602186), the Israel Ministry of Commerce Innovation Authority's Kamin Program (Grant No. 67951), and JOY Ventures. NG, NF, and TH contributed to conceptualization. NG, NF, and TF-S contributed to data collection. NG, TM, GG, GD, and TH contributed to formal analysis. NG, TM, GD, HS, and TH contributed to investigation. NG, TM, GG, GD, HS, and TH contributed to methodology. NG, TM, and GD contributed to visualization. NG contributed to writing the original draft of the article. NG, TM, NF, TF-S, GD, HS, and TH contributed to reviewing and editing the article. NG and TH contributed to project administration. TM, GG, and HS contributed to data curation. HS and TH contributed to funding acquisition. TH contributed to supervision. All authors gave final approval for publication and agreed to be held accountable for the work performed therein. We also thank the Sagol Family Fund for their support. We thank the clinicians and researchers who contributed to patient recruitment for the studies included in this project: Dr. Yotam Pasternak, Dr. Roy Sar-El, Dr. Dan Mirelman, Noam Sarna, Nili Green, Gali Bar, Dana Kinori, Maya Weinstein, Dana Natan, Dana Kariti, Professor Michael Krasnoshtein, Dr. Dalia Brandes, Dr. Oren Tene, Efrat Routledge, Marina Gordon, Dr. Miki Bloch, Zivya Seligman, Daphna Armon, and Dr. Liat. A previous version of this article was published as a preprint on PsyArXiv: https://osf.io/preprints/psyarxiv/v52qb_v1. The analysis code and data supporting the findings of this study are available on the Open Science Framework at https://osf.io/46zfm/. TH is the Chief Medical Scientist and Chair of the advisory board at GrayMatters Health Co., Haifa, Israel, and has stock options. This company sells the platform of Prism for PTSD, neurofeedback driven by an amygdala-related biomarker, which is also used as the neurofeedback probe in this study. All other authors report no biomedical financial interests or potential conflicts of interest.